Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis

[1]  Tony W Wilson,et al.  Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV‐infected older adults , 2015, Human brain mapping.

[2]  Philip S. Yu,et al.  Tensor-Based Multi-view Feature Selection with Applications to Brain Diseases , 2014, 2014 IEEE International Conference on Data Mining.

[3]  C. Chiozzini,et al.  HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation , 2014, PloS one.

[4]  Aixia Guo,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2014 .

[5]  T. Wilson,et al.  Decreased MEG beta oscillations in HIV-infected older adults during the resting state , 2013, Journal of NeuroVirology.

[6]  Tony W. Wilson,et al.  Functional Brain Abnormalities During Finger-Tapping in HIV-Infected Older Adults: A Magnetoencephalography Study , 2013, Journal of Neuroimmune Pharmacology.

[7]  M. Peluso,et al.  Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. , 2013, The Journal of infectious diseases.

[8]  J. Lambert,et al.  The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation. , 2013, The Journal of infectious diseases.

[9]  D. Richman,et al.  Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. , 2013, The New England journal of medicine.

[10]  T. Wilson,et al.  Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain. , 2013, PloS one.

[11]  Debra Hanson,et al.  Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation , 2012, Journal of Clinical Microbiology.

[12]  Jintanat Ananworanich,et al.  Central nervous system viral invasion and inflammation during acute HIV infection. , 2012, The Journal of infectious diseases.

[13]  W. Eddy,et al.  Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease , 2012, Journal of Neuroscience Methods.

[14]  R. Ransohoff,et al.  Innate immunity in the central nervous system. , 2012, The Journal of clinical investigation.

[15]  Lauri Parkkonen,et al.  Functional connectivity measured with magnetoencephalography identifies persons with HIV disease , 2012, Brain Imaging and Behavior.

[16]  Huldrych F. Günthard,et al.  Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. , 2012, JAMA.

[17]  Ying Wu,et al.  Abnormalities in Resting-State Functional Connectivity in Early Human Immunodeficiency Virus Infection , 2011, Brain Connect..

[18]  Susan Morgello,et al.  CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy , 2011, AIDS.

[19]  D. Fuchs,et al.  Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. , 2011, The Journal of infectious diseases.

[20]  E. Rosenberg,et al.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. , 2011, The Journal of infectious diseases.

[21]  Michael J. Taylor,et al.  Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies , 2011, Journal of NeuroVirology.

[22]  Eric S. Rosenberg,et al.  Alterations in brain metabolism during the first year of HIV infection , 2011, Journal of NeuroVirology.

[23]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[24]  J. McArthur,et al.  Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection , 2011, Journal of NeuroVirology.

[25]  Paul M. Thompson,et al.  Subcortical brain atrophy persists even in HAART-regulated HIV disease , 2011, Brain Imaging and Behavior.

[26]  Jianhui Zhong,et al.  Effects of Nadir Cd4 Count and Duration of Human Immunodeficiency Virus Infection on Brain Volumes in the Highly Active Antiretroviral Therapy Era , 2022 .

[27]  J. McArthur,et al.  Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection , 2009, Journal of NeuroVirology.

[28]  Michael Watters,et al.  Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort , 2006, Journal of NeuroVirology.

[29]  S. Gartner,et al.  Insights into the role of immune activation in HIV neuropathogenesis , 2002, Journal of NeuroVirology.

[30]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. , 1996, Journal of magnetic resonance.

[31]  Marco Salemi,et al.  HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[32]  E. Rosenberg,et al.  Soluble CD 163 Made by Monocyte / Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral Therapy , 2011 .

[33]  D. Kolson,et al.  HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities , 2010, Journal of Neuroimmune Pharmacology.

[34]  R. Edelman,et al.  Biomarkers of neurological status in HIV infection: A 3‐year study , 2010, Proteomics. Clinical applications.

[35]  Persephone Borrow,et al.  The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.

[36]  Amalio Telenti,et al.  Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel , 2010 .

[37]  D. Richman,et al.  Resting cerebral blood flow , 2009, Neurology.

[38]  M. Kaul.  HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches , 2009, Current opinion in neurology.

[39]  S. Weis,et al.  White matter changes in HIV-1 infected brains: A combined gross anatomical and ultrastructural morphometric investigation of the corpus callosum , 2009, Clinical Neurology and Neurosurgery.

[40]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[41]  B. Haynes,et al.  Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design , 2008, Journal of Virology.

[42]  P. Borrow,et al.  Innate immune responses in primary HIV-1 infection , 2008, Current opinion in HIV and AIDS.

[43]  J. Bell,et al.  The Neuropathology of HIV/AIDS , 2008, International review of psychiatry.

[44]  R. Edelman,et al.  Whole Brain and Localized Magnetization Transfer Measurements Are Associated with Cognitive Impairment in Patients Infected with Human Immunodeficiency Virus , 2008, American Journal of Neuroradiology.

[45]  B. Brew.  Lost in translation , 2007, Neurology.

[46]  M. Saitoh,et al.  [Case of acute primary HIV infection with menigoencephalitis demonstrating high signal intensity of the bilateral globus pallidus in T2-weighted MRI]. , 2007, Rinsho shinkeigaku = Clinical neurology.

[47]  M. Bennett,et al.  HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes , 2007, Proceedings of the National Academy of Sciences.

[48]  Paul M. Thompson,et al.  3 D pattern of brain atrophy in HIV / AIDS visualized using tensor-based morphometry , 2006 .

[49]  K. Marder,et al.  An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. , 2007, Archives of neurology.

[50]  Sunhee C. Lee,et al.  CD45 Isoform Expression in Microglia and Inflammatory Cells in HIV‐1 Encephalitis , 2006, Brain pathology.

[51]  K. Conant,et al.  Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  A. Ghorpade,et al.  Novel role of TGF‐β in differential astrocyte‐TIMP‐1 regulation: Implications for HIV‐1‐dementia and neuroinflammation , 2006, Journal of neuroscience research.

[53]  Paul M. Thompson,et al.  3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS , 2006, NeuroImage.

[54]  R. Edelman,et al.  Diffusion alterations in corpus callosum of patients with HIV. , 2006, AJNR. American journal of neuroradiology.

[55]  Stuart A. Lipton,et al.  Mechanisms of Neuroimmunity and Neurodegeneration Associated with HIV-1 Infection and AIDS , 2006, Journal of Neuroimmune Pharmacology.

[56]  Kiralee M. Hayashi,et al.  Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Marder,et al.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.

[58]  Y. Liu,et al.  Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort , 2004, Journal of Neuroimmunology.

[59]  A. Lackner,et al.  Activation of the blood-brain barrier by SIV (simian immunodeficiency virus) requires cell-associated virus and is not restricted to endothelial cell activation. , 2004, Biochemical Society transactions.

[60]  Peter Hunt,et al.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.

[61]  K. Conant,et al.  Matrix Metalloproteinase 1 Interacts with Neuronal Integrins and Stimulates Dephosphorylation of Akt* , 2004, Journal of Biological Chemistry.

[62]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.

[63]  H. Gendelman,et al.  Regulation of tissue inhibitor of metalloproteinase‐1 by astrocytes: Links to HIV‐1 dementia , 2003, Glia.

[64]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[65]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[66]  M. Mattson,et al.  HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity , 2001, Journal of neurochemistry.

[67]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[68]  S. Gartner.  HIV Infection and Dementia , 2000, Science.

[69]  E. Major,et al.  Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes , 1999, The Journal of Biological Chemistry.

[70]  Alexander J. Smola,et al.  Support Vector Regression Machines , 1996, NIPS.

[71]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[72]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[73]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[74]  R S Balaban,et al.  Magnetization transfer imaging: practical aspects and clinical applications. , 1994, Radiology.

[75]  W. Wachsman,et al.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection , 1992, Neurology.